Alzheimer’s Disease/Dementia News

A “pitch-shifting” technique may help mitigate privacy risks of digital voice analyses while preserving features needed to determine cognitive health, according to researchers.

Analysis of blood-based biomarkers may be a reliable method to predict behavioral issues in older populations of Asian descent with varied neuropathology, researchers reported in the Journal of Clinical Psychiatry.

People who engage in moderate to vigorous physical activity may be less likely to develop dementia, stroke, anxiety, depression and sleep disorders compared with those with more sedentary behavior, according to preliminary study results.

Over 25 million people globally will be living with Parkinsons’ disease by 2050, according to a new analysis published in BMJ.

Current use of antidepressants corresponded with faster cognitive decline in older adults with dementia, a cohort analysis published in BMC Medicine indicated.

Older adults with cancer had a lower risk for Alzheimer’s disease and related dementias than cancer-free individuals of the same age, according to results of a longitudinal retrospective study.

Phosphorylated tau 217 better detected Alzheimer’s disease pathology across a range of neurodegenerative syndromes compared with other plasma blood-based biomarkers, data from a study in JAMA Neurology show.

The effect of levetiracetam, an antiseizure therapy, on high-frequency oscillation in patients with Alzheimer’s disease as well as epilepsy may prove its viability as a biomarker of disease pathology, according to data.

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health issues, recent data suggest they may improve brain health.